Verrica Pharmaceuticals Inc. (VRCA)
NASDAQ · Healthcare
Verrica Pharmaceuticals Inc. Shareholder Equity 2021–2025
Verrica Pharmaceuticals Inc. annual/quarterly shareholder equity history from 2021 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Verrica Pharmaceuticals Inc. shareholder equity for the quarter ending December 31, 2025 were 24.7M, a 350.94% decrease year-over-year.
- Verrica Pharmaceuticals Inc. shareholder equity for 2025 were 24.7M, a 350.94% decrease from 2024.
- Verrica Pharmaceuticals Inc. shareholder equity for 2024 were -9.9M, a 149.89% decrease from 2023.
- Verrica Pharmaceuticals Inc. shareholder equity for 2023 were 19.8M, a 50.63% decrease from 2022.
- Verrica Pharmaceuticals Inc. shareholder equity for 2022 were 40.0M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Verrica Pharmaceuticals Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $25 |
| 2024 | $-10 |
| 2023 | $20 |
| 2022 | $40 |
| 2021 | $33 |
| Verrica Pharmaceuticals Inc. Quarterly Shareholder Equity (Millions of US $) | |
|---|---|
| 2025-12-31 | $25 |
| 2024-12-31 | $-10 |
| 2023-12-31 | $20 |
| 2022-12-31 | $40 |
| 2021-12-31 | $33 |
Verrica Pharmaceuticals Inc. Shareholder Equity — FAQ
Verrica Pharmaceuticals Inc. (VRCA) shareholder equity over the last 5 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see VRCA's shareholder equity history?
The chart and table above show Verrica Pharmaceuticals Inc.'s shareholder equity by year and by quarter, including the growth rate.